Success Metrics

Clinical Success Rate
81.8%

Based on 36 completed trials

Completion Rate
82%(36/44)
Active Trials
1(2%)
Results Posted
31%(11 trials)
Terminated
8(14%)

Phase Distribution

Ph phase_1
3
5%
Ph not_applicable
7
12%
Ph phase_3
11
19%
Ph phase_2
6
10%
Ph phase_4
31
53%

Phase Distribution

3

Early Stage

6

Mid Stage

42

Late Stage

Phase Distribution58 total trials
Phase 1Safety & dosage
3(5.2%)
Phase 2Efficacy & side effects
6(10.3%)
Phase 3Large-scale testing
11(19.0%)
Phase 4Post-market surveillance
31(53.4%)
N/ANon-phased studies
7(12.1%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

81.8%

36 of 44 finished

Non-Completion Rate

18.2%

8 ended early

Currently Active

1

trials recruiting

Total Trials

59

all time

Status Distribution
Active(2)
Completed(36)
Terminated(8)
Other(13)

Detailed Status

Completed36
unknown13
Terminated8
Not yet recruiting1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
59
Active
1
Success Rate
81.8%
Most Advanced
Phase 4

Trials by Phase

Phase 13 (5.2%)
Phase 26 (10.3%)
Phase 311 (19.0%)
Phase 431 (53.4%)
N/A7 (12.1%)

Trials by Status

terminated814%
unknown1322%
not_yet_recruiting12%
recruiting12%
completed3661%

Recent Activity

Clinical Trials (59)

Showing 20 of 59 trialsScroll for more
NCT07711171Phase 4

Efficacy and Safety of Canagliflozin in the Treatment of Type 2 Diabetes With Mild Cognitive Impairment

Recruiting
NCT07122102Not Applicable

A Multicenter, Randomized, Open-Label, Parallel-Controlled Clinical Study Comparing the Efficacy and Safety of Cofrogliptin Versus Acarbose in Drug-Naïve Patients With Type 2 Diabetes

Not Yet Recruiting
NCT02953093Phase 2

Study of Acarbose in Longevity

Terminated
NCT01514838Phase 3

A Study to Assess the Efficacy and Safety of ASP1941 in Asian Subjects With Type 2 Diabetes Mellitus

Terminated
NCT03380546Phase 3

Acarbose and Prandial Insulin for the Treatment of Gestational Diabetes Mellitus.

Terminated
NCT02589353Phase 4

Human Oral Detection of Glucose Olygomers

Completed
NCT05629806Phase 3

Effect of Acarbose and Mixture of Pioglitazone and Metformin in Patients With Type 2 Diabetes

Unknown
NCT02446834Not Applicable

Research of Intensive Lifestyle Intervention for PCOS Patients With IGT

Completed
NCT04180813

Real-world Study Comparing the Adherence and Effectiveness of Linagliptin vs. Acarbose

Terminated
NCT03794336Phase 4

Efficacy and Safety of Alogliptin vs. Acarbose in Chinese Type 2 Diabetes Mellitus (T2DM) Patients With High CV Risk or CHD Treated With Aspirin and Inadequately Controlled With Metformin Monotherapy or Drug Naive

Completed
NCT02836704Phase 4

Comparison of Standard vs Higher Starting Dose of Insulin Glargine in Chinese Patients With Type 2 Diabetes (Glargine Starting Dose)

Completed
NCT03359837Phase 4

Comparison of Two Treatment Regimens in Patients With Type 2 Diabetes After Short-term Intensive Insulin Therapy

Completed
NCT01019356Not Applicable

Role of Insulin Action and Free Fatty Acids in Hyperandrogenism of Women With Polycystic Ovary Syndrome

Completed
NCT03344341Phase 4

A Phase IV Study in Drug-Naive Patients With T2DM in China

Terminated
NCT01914133Phase 2

Acarbose and Older Adults With Postprandial Hypotension

Completed
NCT02685852Phase 1

Evaluating Exenatide for the Treatment of Postprandial Hyperinsulinemic Hypoglycemia

Completed
NCT01490918Phase 4

Study to Evaluate the Efficacy of Acarbose,Metformin,Sitagliptin Combination Treatment in DM Patients

Completed
NCT03349684Phase 3

Loose-dose Combination of Acarbose and Metformin for T2DM in Metformin-failure Patients

Completed
NCT01181674Phase 4

Remission Evaluation of Metabolic Interventions in Type 2 Diabetes (REMIT Pilot Trial)

Completed
NCT03241303Not Applicable

Delineation of the Role of Glucagon-like Peptide-1 Signalling in Relation to Increased Carbohydrate Content in the Distal Small Intestines

Completed

Drug Details

Intervention Type
DRUG
Total Trials
59